Topical Steroids Interactions

15 interactions on record

May increase glucose-lowering effect of glimepiride, increasing susceptibility to hypoglycemia.

Source: NLP:glimepiride

Lessen the skin test wheal and erythema responses elicited by histamine at the skin test site. Should be discontinued for at least 2-3 weeks before skin testing.

Source: NLP:histamine

May decrease serum thyroxine-binding globulin concentration, resulting in initial transient increase in FT4 followed by decreased serum T4.

Source: NLP:levothyroxine sodium

May decrease serum thyroxine-binding globulin concentration, altering T3 serum transport. Closely monitor thyroid hormone parameters.

Source: NLP:liothyronine sodium

Concomitant use may lead to hypokalemia development. Use with caution and monitor potassium levels.

Source: NLP:methazolamide

May elevate and prolong serum methotrexate levels and increase toxicity; can be continued or reduced gradually in responding patients.

Source: NLP:methotrexate

Somatropin may alter clearance of sex steroids metabolized by CYP450 liver enzymes; careful monitoring is advised.

Source: NLP:somatropin

Ipratropium bromide HFA inhalation aerosol has been used concomitantly with oral steroids in COPD treatment; no formal studies fully evaluating interaction effects with respect to safety and effectiveness.

Source: NLP:ipratropium bromide inhalation